Literature DB >> 34904081

Clinical and electroencephalogram characteristics and treatment outcomes in children with benign epilepsy and centrotemporal spikes.

Rui-Hua Chen1, Bing-Fei Li2, Jian-Hua Wen3, Chun-Lan Zhong4, Ming-Ming Ji4.   

Abstract

BACKGROUND: Epilepsy is a syndrome characterized by transient, rigid, paroxysmal, and repetitive central nervous system dysfunction. Prevention, control, and improvement of cognitive and behavioral dysfunction are of great significance for improving the patients' intellectual development and quality of life. Electroencephalograms (EEG) can predict an accelerated decline in cognitive function. AIM: To determine the clinical and EEG characteristics and treatment results of benign epilepsy in spiking children.
METHODS: A total of 106 cases of benign epilepsy in children with myocardial spines treated at our hospital from January 2017 to January 2020 were selected. Differences in clinical data and EGG characteristics between treatment-effective/-ineffective patients were analyzed, and children's intellectual development before and after treatment evaluated using the Gesell Development Diagnostic Scale.
RESULTS: EEG showed that the discharge proportion in the awake and sleep periods was 66.04%, and the peak/peak discharge was mainly single-sided, accounting for 81.13%, while the discharge generalization accounted for 31.13%. There was no significant difference in any of these variables between sexes and ages (P > 0.05). The proportion of patients with early onset (< 5 years old) and seizure frequency > 3 times/half a year was 40.00% and 60.00%, respectively; the incidence rate and seizure frequency in the younger age group (< 5 years old) were significantly higher than those in the treatment-effective group (P < 0.05), while the discharge index was significantly lower than that in the treatment-effective group (P < 0.05). The discharge index was negatively correlated with fine motor skill and language development (r = -0.274 and -0.247, respectively; P < 0.05), but not with the rest (P > 0.05). Logistic regression analysis showed that low age onset (< 5 years old) and seizure frequency were the factors affecting ineffective-treatment of benign epilepsy in children (odds ratio = 11.304 and 5.784, respectively; P < 0.05). The discharge index of the responsive group after treatment was significantly lower than that of the unresponsive group (P < 0.05). However, there was no significant difference between groups after treatment in gross and fine motor skills, adaptability, language, and personal social development (P > 0.05).
CONCLUSION: The EEG of children with benign epilepsy due to spinal wave in central time zone has characteristic changes, and the therapeutic effect is influenced by age of onset and attack frequency. ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Benign epilepsy; Centrotemporal spikes; Children; Electroencephalogram; Therapeutic effect

Year:  2021        PMID: 34904081      PMCID: PMC8638062          DOI: 10.12998/wjcc.v9.i33.10116

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


Core Tip: The electroencephalogram of children with benign epilepsy with centrotemporal spikes has characteristic changes, and the therapeutic effect is affected by the age and attack frequency of the children at the time of onset.

INTRODUCTION

Epilepsy is a syndrome characterized by transient, rigid, paroxysmal, and repetitive central nervous system dysfunction, generally caused by excessive neuron synchronization in the brain and self-limited abnormal discharge caused by various etiological factors. As a common disease among children, the incidence rate of epilepsy has shown an increasing trend in recent years. Benign epilepsy in children with centrotemporal spike waves is an age-dependent epileptic syndrome, which generally peaks between 6–8 years old, with normal mental and motor development[1,2]. At present, the primary goal of antiepileptic treatments is to completely control epileptic seizures, while simultaneously considering prevention, control, and improvement of cognitive and behavioral dysfunction is of great significance for improving the patients’ intellectual development and quality of life. Electroencephalogram (EEG) is an important external validator of normal brain structure and function and useful to detect some brain alterations. Cognitive function, an important aspect of brain function, is also based on brain morphology and/or function. Studies have shown that abnormal EEG can predict an accelerated decline in cognitive function[3,4]. In this study, the clinical and EEG characteristics of children with benign epilepsy and centrotemporal spikes were analyzed, and the children’s treatment and outcomes also discussed.

MATERIALS AND METHODS

Patients

A total of 106 cases of benign epilepsy, including 66 males and 40 females, in children with spinous waves in the central temporal region were treated at our hospital from January 2017 to January 2020. Their ages ranged from 3 to 12 years old, and their average age was 7.15 ± 1.82 years old. The inclusion criteria were: (1) The diagnosis met the criteria for the epilepsy diagnosis and treatment guidelines of the International League Against Epilepsy; (2) First-time treatment; (3) Aged 3–12 years old; (4) Complete clinical, EEG, and follow-up data; (5) Had intelligence tests; and (6) Informed consent from the child’s guardian. The exclusion criteria were: (1) A history of encephalitis, meningitis, brain developmental malformation, and other brain diseases; (2) Other diseases such as connective tissue disease, nephrotic syndrome, and immunodeficiency; and (3) Patients with a history of glucocorticoid and other treatments within 6 mo before treatment in our hospital.

Treatment and follow-up

The children were treated with levetiracetam and lamotrigine. The levetiracetam dose was 10 mg/kg/d, and the final therapeutic dose was 10-30 mg/kg/d. Lamotrigine was administered at doses from 0.3-0.6 mg/kg/d, gradually increasing to 3-6 mg/kg/d. Each child was followed for 1 year after treatment, and the treatment was considered ineffective if there were clinical epileptic seizures during the follow-up period, and effective if there were no clinical epileptic seizures.

EEG examination

We employed an EEG-1200C manufactured by Japan Optoelectronics Co., Ltd with the following parameters: Gain, 50 µV; high-pass filtering conducted at 45 Hz; time constant, 0.3 s; accuracy, 16 bit; frequency, 200 Hz; and scalp resistance, ≤ 5000 MΩ. Reference electrodes were placed on the bilateral earlobes and we used 16 recording electrodes in total. EEG signals were recorded in a quiet and eye-closed state for 5 min, and the complexity was calculated. The human electroencephalogram frequency was (0.5-30) Hz, including β (13.5-30.0) Hz, α (8.0–13.0) Hz, θ (4.0-7.5) Hz, and δ (1.0-3.5) Hz.

Intelligence development test

The development of children’s intelligence was assessed using the Gesell Development Diagnostic Scale, which included five domains, namely, gross motor, fine motor, adaptability, language, and personal-social ability. The test result of each domain is expressed as development quotient (DQ), and a DQ > 85 was considered normal.

Statistical analysis

SPSS22.0 software was used for data analyses. Measurement data with a normal distribution are expressed as the mean ± SD, and t test was used for comparison between groups. Count data are expressed as n (%), and inter-group comparisons were performed by the chi-square test. Pearson correlation analysis for correlation, and logistic regression analysis for multivariate analysis were also performed. P values < 0.05 were considered statistically significant.

RESULTS

Children's EEG characteristics

Among the 106 children, the EEG showed a discharge proportion in the awake and sleep periods of 66.04%, a spike/sharp wave discharge rate of 81.13% (mainly unilateral discharge), and a discharge generalization rate of 31.13%, as shown in Table 1.
Table 1

Electroencephalogram characteristics of children

Electroencephalogram characteristic
Number of cases
Proportion (%)
Discharge period
Awake and sleep periods7066.04
Sleep period3633.96
Spine/spike discharge
Unilateral8681.13
Bilateral2018.87
Discharge generalization3331.13
Electroencephalogram characteristics of children

Comparison of children’s EEG characteristics with respect to sex and age

There was no significant difference in the proportion of discharge, spike/sharp wave unilateral discharge, and discharge generalization between the sexes and among all age groups either during the awake or asleep period (P > 0.05), as shown in Table 2.
Table 2

Comparison of electroencephalogram characteristics of children of different sexes and ages

Group
Number of cases
Awake and sleep discharge (%)
Spike/sharp wave unilateral discharge (%)
Discharge generalization (%)
Gender
Man6642 (63.64)55 (83.33)19 (28.79)
Woman4028 (70.00)31 (77.50)14 (35.00)
χ 2 0.450 0.554 0.448
P value0.502 0.457 0.503
Age
≤ 7 yr3425 (73.53)26 (76.47)11 (32.35)
> 7 yr7245 (62.50)60 (83.33)22 (30.56)
χ 2 1.2530.7110.035
P value0.2630.3990.852
Comparison of electroencephalogram characteristics of children of different sexes and ages

Comparison of clinical data of treatment responsive/unresponsive children

The proportion of children with young-age onset (< 5 years old) and attack frequency > 3 times/half a year in the treatment unresponsive group was significantly higher than that in the treatment responsive group (P < 0.05), and the discharge index significantly lower (P < 0.05). There was no significant difference in sex, age, or discharge period between the treatment responsive/unresponsive groups (P > 0.05, Table 3).
Table 3

Comparison of clinical data of children with and without effective treatment, n (%)

Clinical data
Treatment ineffective (n = 20)
Treatment effective (n = 86)
t /χ2
P value
Gender0.5540.457
Man11 (55.00)55 (63.95)
Woman9 (45.00)31 (36.05)
Age (yr)7.15 ± 1.987.15 ± 1.800.0001.000
Discharge period0.8830.347
Awake and sleep periods15 (75.00)55 (63.95)
Sleep period5 (25.00)31 (36.05)
Spike/sharp wave discharge2.0810.149
Unilateral19 (95.00)67 (77.91)
Bilateral1 (5.00)19 (22.09)
Discharge generalization8 (40.00)25 (29.07)0.9040.342
Low age onset (< 5 yr)8 (40.00)6 (6.98)12.6900.000
Seizure frequency9.5820.002
> 3 times/half a year12 (60.00)21 (24.42)
≤ 3 times/half a year8 (40.00)65 (75.58)
Discharge index (%)65.05 ± 7.7473.28 ± 9.17-3.714 0.000
Gesell scale
Gross motor (points)85.70 ± 6.6285.28 ± 7.290.236 0.814
Fine motor (points)88.60 ± 5.9986.62 ± 8.001.040 0.301
Adaptability (points)87.60 ± 7.0286.08 ± 7.200.854 0.395
Language (points)88.15 ± 7.1386.33 ± 7.920.942 0.348
Individual-social ability (points)85.40 ± 8.6185.99 ± 8.22-0.287 0.775
Comparison of clinical data of children with and without effective treatment, n (%)

Correlation between discharge index and Gesell scale

Pearson correlation analysis showed a negative correlation between the discharge index and fine motor skills and the language development quotient (r = − 0.274 and − 0.247, respectively; P < 0.05), but no significant correlation was observed in any other parameters (P > 0.05), as shown in Table 4 and Figure 1.
Table 4

Results of correlation analysis

Gesell scale
Discharge index
r
P value
Gross motor-0.0140.887
Fine motor-0.2740.005
Adaptability-0.0680.488
Language-0.2470.011
Individual-social ability0.0980.316
Figure 1

Correlation analysis. A: Fine motion; B: Language.

Correlation analysis. A: Fine motion; B: Language. Results of correlation analysis

Results of multivariate analysis

Logistic regression analysis was performed using the above statistically significant indicators as independent variables and treatment effectiveness as the dependent variable. The results showed that low age (< 5 years old) and seizure frequency were the factors affecting the lack of treatment response in children with benign epilepsy and centrotemporal spike wave (Odds ratio = 11.304 and 5.784, respectively; P < 0.05), as shown in Table 5.
Table 5

Results of multivariate analysis

Index
β
SE
Wals
P value
OR (95%CI)
Incidence at a young age (< 5 yr)2.4250.69612.1310.00011.304 (2.888-44.251)
Attack frequency1.7550.5938.7600.0035.784 (1.809-18.490)
Constant term-2.6860.48031.2540.000-

OR: Odds ratio.

Results of multivariate analysis OR: Odds ratio.

Comparison of discharge index and Gesell scale between treatment responsive/unresponsive children before and after treatment

The discharge index after treatment in the treatment responsive group was 34.47 ± 10.02%, significantly lower than that in the unresponsive group (P < 0.05). In the treatment responsive group, fine motor skills, adaptability, and language development quotient improved after treatment (P < 0.05). There was no significant difference in gross and fine motor skills, adaptability, language, or personal-social ability development quotient between the treatment responsive/unresponsive group after treatment (P > 0.05, Table 6).
Table 6

Comparison of discharge index and Gesell scale scores between treatment-effective and treatment-ineffective children before and after treatment

Index
Treatment ineffective (n = 20)
Treatment effective (n = 86)
t
P value
Discharge index (%)
Before treatment65.05 ± 7.7473.28 ± 9.17-3.714 0.000
After treatment40.15 ± 5.3634.47 ± 10.022.449 0.016
t 11.828 26.498
P value0.000 0.000
Gross motor (points)
Before treatment85.70 ± 6.6285.28 ± 7.290.236 0.814
After treatment85.90 ± 5.4786.20 ± 6.47-0.192 0.848
t -0.104 -0.875
P value0.918 0.383
Fine motor (points)
Before treatment88.60 ± 5.9986.62 ± 8.001.040 0.301
After treatment91.20 ± 2.6989.24 ± 5.291.605 0.111
t -1.771 -2.533
P value0.085 0.012
Adaptability (points)
Before treatment87.60 ± 7.0286.08 ± 7.200.854 0.395
After treatment88.50 ± 5.0488.26 ± 5.380.182 0.856
t -0.466 -2.249
P value0.644 0.026
Language (points)
Before treatment88.15 ± 7.1386.33 ± 7.920.942 0.348
After treatment89.35 ± 6.0288.55 ± 5.990.537 0.592
t -0.575 -2.073
P value0.569 0.040
Personal-social ability (points)
Before treatment85.40 ± 8.6185.99 ± 8.22-0.287 0.775
After treatment86.95 ± 6.7887.91 ± 6.27-0.607 0.545
t -0.633 -1.722
P value0.531 0.087
Comparison of discharge index and Gesell scale scores between treatment-effective and treatment-ineffective children before and after treatment

DISCUSSION

Epilepsy is a brain disease mainly characterized by transient central nervous system dysfunction caused by abnormal neuron discharge. Repeated epileptic seizures are often accompanied by a variety of neurobiological, cognitive, psychological, and social dysfunctions. Benign epilepsy with spinous waves in the central temporal region is the most common partial epilepsy in childhood, with an onset age between 3-13 years and accounting for 15%-24% of all kinds of epilepsy in children[5]. Several studies have shown that children with epilepsy and centrotemporal spikes have various degrees of cognitive and behavioral damage[6,7], while other reports have found that the cognitive impairment in these children is not caused by seizures but related to frequent clinical discharge. Neuropsychological and sociological problems exist in half of these children after adulthood[8,9]. Although the primary goal of antiepileptic treatment is to completely control epileptic seizures, prevention, control, and improvement of cognitive and behavioral dysfunction must be simultaneously considered. Therefore, clinicians must achieve a balance between controlling the epileptic seizures as much as possible and preserving cognitive and behavioral functions[10]. Long-term outbreaks of spike-and-slow wave rhythm and bilateral asynchronous spike-and-slow wave distribution cause more severe cognitive impairment than single spike waves[11]. EEG monitoring, a common modern auxiliary examination method for the clinical diagnosis of mild cognitive impairment diseases, induces no physical trauma and has confirmed value in the diagnosis of brain diseases. However, comprehensive analyses, as well as other experimental and auxiliary examinations, need to be conducted based on specific symptoms and signs; therefore, it is of great clinical significance to explore chemical markers of brain damage[12]. EEG represents the waveforms formed by the brain spontaneous potential; these waveforms can be divided into α, β, γ, θ, and δ waves according to their frequencies, with different waveforms being shown at different ages, in various consciousness states, and at various brain function levels[13,14]. Some studies have shown that abnormal EEGs can predict an accelerated decline in cognitive function. In children with epilepsy, EEGs accompanied by spinous waves in the central temporal region during the attack stage are often characterized by tonic-clonic seizures, where the initial fast wave activity of low amplitude in the central or middle temporal region on one side gradually increases in amplitude and decreases in frequency, gradually evolving into the alternating appearance of spinous and slow waves, which can be generalized to the ipsilateral hemisphere or even spread to the contralateral one[15]. At present, EEGs are considered to be highly related to epilepsy with spinous waves in the central temporal region. And compared with those of healthy peers, an increase in extremely high-amplitude spinous and slow waves in the high Rolandic region can be observed in the awake period, along with a widespread rhythmic outbreak of 2-3 Hz high-amplitude spinous and slow waves in the awake period. However, the discharge is significantly increased in the sleep period, and the spinous and slow wave discharge index is > 50% during the non-rapid-eye-movement sleep period[16]. In epilepsy accompanied by centrotemporal spikes, the presence of a status epilepticus EEG during sleep is known to cause nerve damage and cognitive changes; the higher the abnormal discharge index in the EEG, the more severe the cognitive damage in children. Therefore, we should actively diagnose, treat, and observe the therapeutic effects in children with epilepsy accompanied by centrotemporal spikes[17,18]. In this study, correlation analysis revealed that the discharge index was negatively correlated with fine motor performance and the language development quotient. Logistic regression analysis showed that an early age of onset (< 5 years old) and seizure frequency were influencing factors for the unresponsive treatment of benign epilepsy with centrotemporal spikes in children, indicating that monitoring the EEG discharge index could be used to preliminarily determine the children’s fine motor skills and language development quotient. During treatment, great attention should be given to children with early-onset and frequent seizures in whom clinical treatment has a poor effect. Frequent attacks can lead to delayed reaction time or even reaction loss in children, suggesting that abnormal discharges may be accompanied by transient cognitive function changes under clinical conditions, which reminds us that seizure control should not be the target of clinical treatment but the inhibition of clinical discharge and subsequent improvement in patients’ cognitive function[19,20]. An early age of onset is an important factor leading to poor treatment effect in children with benign epilepsy and centrotemporal spikes. Given the lack of clear clinical data on the specific scope of early-onset benign epilepsy with centrotemporal spikes, an early age at onset can be used as a relevant factor to predict treatment prognosis in these children. In this study, early age of onset was < 5 years old. The analysis of the results of this study showed that the two antiepileptic drugs levetiracetam and lamotrigine could effectively control epileptic seizures and inhibit epileptic discharge, thus improving children’s cognitive function. However, this study has various limitations. Due to the limited number of enrolled children, there may be some deviation and error in the evaluation of discharge index, which may lead to a lack of generalizability. Therefore, further research expanding the sample size and extending follow-up time is needed.

CONCLUSION

In summary, the EGG of children with benign epilepsy and centrotemporal spikes has characteristic changes, and therapeutic effects are affected by the age and attack frequency at the time of onset.

ARTICLE HIGHLIGHTS

Research background

The primary goal of antiepileptic treatments is to completely control epileptic seizures, while simultaneously considering prevention, control, and improvement of cognitive and behavioral dysfunction is of great significance for improving the patients’ intellectual development and quality of life.

Research motivation

In this study, the clinical and electroencephalograms (EEG) characteristics of children with benign epilepsy and centrotemporal spikes were analyzed, and the children’s treatment and outcomes also discussed.

Research objectives

This study aimed to determine the clinical and EEG characteristics and treatment results of benign epilepsy in spiking children.

Research methods

A total of 106 benign epilepsy children with myocardial spines were included. Differences in clinical data and EGG characteristics between treatment-effective/-ineffective patients were analyzed, and children’s intellectual development before and after treatment evaluated using the Gesell Development Diagnostic Scale.

Research results

EEG showed that the discharge proportion in the awake and sleep periods was 66.04%, and the peak/peak discharge was mainly single-sided, accounting for 81.13%, while the discharge generalization accounted for 31.13%. The discharge index was negatively correlated with fine motor skill and language development, but not with the rest. The discharge index of the responsive group after treatment was significantly lower than that of the unresponsive group.

Research conclusions

The EGG of children with benign epilepsy and centrotemporal spikes has characteristic changes, and therapeutic effects are affected by the age and attack frequency at the time of onset.

Research perspectives

Further research expanding the sample size and extending follow-up time is needed.
  19 in total

1.  Effect of Levetiracetam on Cognitive Function and Clonic Seizure Frequency in Children with Epilepsy.

Authors:  Shihao Zhou; Qiong Zhan; Xiaomei Wu
Journal:  Curr Mol Med       Date:  2019       Impact factor: 2.222

2.  EEG source localization.

Authors:  Christoph M Michel; Bin He
Journal:  Handb Clin Neurol       Date:  2019

3.  Clinical and electroencephalographic correlates of psychiatric features in children with frontal lobe epilepsy.

Authors:  Chiara Ticci; Teresa Luongo; Giulia Valvo; Anna Rita Ferrari; Paola Brovedani; Gabriele Masi; Simona Pellacani; Federico Sicca
Journal:  Epilepsy Behav       Date:  2019-02-04       Impact factor: 2.937

4.  Comorbidity and Childhood Epilepsy: A Nationwide Registry Study.

Authors:  Kari Modalsli Aaberg; Inger Johanne Bakken; Morten I Lossius; Camilla Lund Søraas; Siri Eldevik Håberg; Camilla Stoltenberg; Pål Surén; Richard Chin
Journal:  Pediatrics       Date:  2016-08-01       Impact factor: 7.124

5.  Pretreatment seizure semiology in childhood absence epilepsy.

Authors:  Sudha Kilaru Kessler; Shlomo Shinnar; Avital Cnaan; Dennis Dlugos; Joan Conry; Deborah G Hirtz; Fengming Hu; Chunyan Liu; Eli M Mizrahi; Solomon L Moshé; Peggy Clark; Tracy A Glauser
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910

6.  Correlation of EEG with neuropsychological status in children with epilepsy.

Authors:  David A Hsu; Katherine Rayer; Daren C Jackson; Carl E Stafstrom; Murielle Hsu; Peter A Ferrazzano; Kevin Dabbs; Gregory A Worrell; Jana E Jones; Bruce P Hermann
Journal:  Clin Neurophysiol       Date:  2015-08-20       Impact factor: 3.708

7.  Electroencephalographic abnormalities are correlated with cognitive deficits in children with benign childhood epilepsy with centrotemporal spikes: A clinical study of 61 cases.

Authors:  Jun Zhang; Haoran Yang; Dan Wu; Chenxi Yang; Yanfeng Yang; Wei Zhou; Xiaoling Zhang; Wei Sun
Journal:  Epilepsy Behav       Date:  2020-03-13       Impact factor: 2.937

8.  Focal cortical hypermetabolism in atypical benign rolandic epilepsy.

Authors:  Sarah R Curnow; Simon J Vogrin; Sarah Barton; Catherine A Bailey; A Simon Harvey
Journal:  Epilepsy Res       Date:  2020-02-10       Impact factor: 3.045

9.  Role of inflammation in childhood epilepsy and ADHD comorbidity.

Authors:  Marwa Elhady; Rasha Sobhy Elattar; Asmaa Mohamed Ali Elaidy; Naglaa Abdelmoniem Abdallah; Heba A Elmalt
Journal:  Appl Neuropsychol Child       Date:  2020-08-25       Impact factor: 1.493

10.  Cognitive Function and Neuropsychological Comorbidities in Children with Newly Diagnosed Idiopathic Epilepsy.

Authors:  Seung Yun Lee; Jang Ho Park; Sin Jae Park; Yangho Kim; Kyung Yeon Lee
Journal:  J Korean Med Sci       Date:  2018-01-15       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.